CIHR Operating Grant: Evaluation of Harm Reduction Approaches to Address the Opioid Crisis in the Context of COVID-19

Maximum Value

250,000 

Sponsor Deadline

November 12, 2021

Internal Deadline

November 9, 2021 at 12:00 pm

NOI Deadline

N/A

LOI Deadline

N/A

Program Description

The intersection of COVID-19 and substance use represents the confluence of two severe public health crises, with the COVID-19 pandemic compounding the ongoing opioid crisis. There is a clear increased risk of harm to people who use drugs or who have a substance use disorder in the COVID-19 context due to self-isolation requirements, physical distancing measures, and/or an increasingly toxic illegal drug supply. CIHR is launching this evaluation-focused funding opportunity to address harm reduction approaches to the opioid crisis and to better understand its compounding intersection with the COVID-19 pandemic.

Full Program Terms


Proposal Development Support

For support in preparing a UBCO-led application, please get in touch with the contact below:

Stacey Leavitt

stacey.leavitt@ubc.ca


How to Apply

https://www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?prog=3380&view=search&launchMonth=10&launchYear=2020&type=EXACT&resultCount=25&next=1


Last updated: 2022-11-08 10:27

Leave a Reply